array:20 [
  "pii" => "X0211699505019316"
  "issn" => "02116995"
  "estado" => "S300"
  "fechaPublicacion" => "2005-12-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia. 2005;25:718-9"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 3414
    "formatos" => array:3 [
      "EPUB" => 285
      "HTML" => 2615
      "PDF" => 514
    ]
  ]
  "Traduccion" => array:1 [
    "en" => array:16 [
      "pii" => "X2013251405019313"
      "issn" => "20132514"
      "estado" => "S300"
      "fechaPublicacion" => "2005-12-01"
      "documento" => "article"
      "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
      "subdocumento" => "fla"
      "cita" => "Nefrologia (English Version). 2005;25:718-9"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 2087
        "formatos" => array:3 [
          "EPUB" => 146
          "HTML" => 1728
          "PDF" => 213
        ]
      ]
      "en" => array:5 [
        "idiomaDefecto" => true
        "titulo" => "Alpha-interferon renal toxicity"
        "tieneTextoCompleto" => 0
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "718"
            "paginaFinal" => "719"
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "C. Carmo, H. Sá, M.F. Xavier da Cunha, M. Campos"
            "autores" => array:1 [
              0 => array:1 [
                "nombre" => "C. Carmo, H. Sá, M.F. Xavier da Cunha, M. Campos"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "en" => array:8 [
          "pii" => "X0211699505019316"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699505019316?idApp=UINPBA000064"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251405019313?idApp=UINPBA000064"
      "url" => "/20132514/0000002500000006/v0_201502091553/X2013251405019313/v0_201502091553/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:16 [
    "pii" => "X0211699505019308"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2005-12-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2005;25:720"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 5143
      "formatos" => array:3 [
        "EPUB" => 284
        "HTML" => 3843
        "PDF" => 1016
      ]
    ]
    "es" => array:9 [
      "idiomaDefecto" => true
      "titulo" => "EL CATETER VENOSO CENTRAL CRÓNICO TUNELIZADO AUMENTA LA MORTALIDAD EN HEMODIALISIS"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "720"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Chronic tunneled central venous catheter increases mortality in hemodialysis"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "J. Fernández-Gallego, V. López, M.A. Martín, R. Toledo"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "J. Fernández-Gallego, V. López, M.A. Martín, R. Toledo"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:8 [
        "pii" => "X2013251405019305"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251405019305?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699505019308?idApp=UINPBA000064"
    "url" => "/02116995/0000002500000006/v0_201502091332/X0211699505019308/v0_201502091333/es/main.assets"
  ]
  "itemAnterior" => array:16 [
    "pii" => "X0211699505019324"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2005-12-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2005;25:712-7"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 6650
      "formatos" => array:3 [
        "EPUB" => 296
        "HTML" => 5415
        "PDF" => 939
      ]
    ]
    "es" => array:9 [
      "idiomaDefecto" => true
      "titulo" => "NEFROPATÍA IGA CON PROLIFERACIÓN EXTRACAPILAR Y ANCA POSITIVOS"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "712"
          "paginaFinal" => "717"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "IgA nephropathy with crescentic glomerulonephritis and ANCA positive"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "J. Ara, J. Bonet, R. Rodríguez, E. Mirapeix, I. Agraz, R. Romero"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "J. Ara, J. Bonet, R. Rodríguez, E. Mirapeix, I. Agraz, R. Romero"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:8 [
        "pii" => "X2013251405019321"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251405019321?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699505019324?idApp=UINPBA000064"
    "url" => "/02116995/0000002500000006/v0_201502091332/X0211699505019324/v0_201502091333/es/main.assets"
  ]
  "en" => array:8 [
    "idiomaDefecto" => true
    "titulo" => "ALPHA-INTERFERON RENAL TOXICITY"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "718"
        "paginaFinal" => "719"
      ]
    ]
    "autores" => array:1 [
      0 => array:2 [
        "autoresLista" => "C. Carmo, H. Sá, M.F. Xavier da Cunha, M. Campos"
        "autores" => array:1 [
          0 => array:1 [
            "nombre" => "C. Carmo, H. Sá, M.F. Xavier da Cunha, M. Campos"
          ]
        ]
      ]
    ]
    "textoCompleto" => "NEFROLOGÍA. Volumen 25. Número 6. 2005 CARTAS Alpha-interferon renal toxicity C. Carmo*, H. Sá*, M. F. Xavier da Cunha** y M. Campos* *Servicio de Nefrología. Hospitais da Universidade de Coimbra. **Servicio de Anatomía Patológica. Hospitais da Universidade de Coimbra. Sr. Director: In 1982, the demonstrations of growth inhibiting properties led to the first clinical trials with IFN- , as a biological agent used in cancer treatment. Since then, it have been applied in the treatment of several malignancies and several adverse effects were reported1. CASE A 39 years old caucasian female, on the 9th january 2001, was observed for obnubilation. She had high blood pressure, anaemia, thrombocytopenia, moderate renal failure and an increase of serum LDH levels. She suffered from chronic myeloid leukaemia (CML) treated with IFN- , hydroxyurea and cytarabine, during 48 months, with haematological response. She had no other relevant antecedents and did not take other drugs. The patient was admitted to complementary study, cancer treatment was discontinued and anti-hypertensive treatment was started. During the first inpatient week she complained of orthopnoea, oedema and oliguria. Analysis revealed a non-immune haemolytic anaemia (Hg-7,9 g/dl, haptoglobin < 0,058 g/l, negative Combs tests, peripheral blood film showed schistocytes and spherocytes, LDH > 1.000 U/L) and renal function deterioration (ureic nitrogen-53 mg/dl and creatinine-6,8 mg/dl). The microbiological study of blood, urine and stools were negative. HBV, HCV and HIV serologies were negative. Serum values of C3 and C4 complement fractions were normal. Searches for circulating immune complexes, cryoglobulin, auto-antibodies were negative. Urinalysis showed proteinuria of 1.2 Correspondencia: Dra. Carmen do Carmo Servicio de Nefrología Hospitais da Universidade de Coimbra Avda. Dr. Bissaya Barreto, 52 3000-075 Coimbra (Portugal) E-mail: pmgf@mail.telepac.pt Fig. 1.--There is marked intimal edema, proliferation as well as necrosis. The vascular lumen is occluded by thrombi. The glomerular tuft is shrinked and the capilary wall is thickened showing double-contour (MT, × 200). g in 24 hours. Pregnancy test was negative. Renal ultrasound was normal. The histological study of the renal biopsy specimen revealed thrombotic microangiopathy (TM) (fig. 1). The clinical evaluation and the complementary study enabled the diagnosis of hemolytic uremic syndrome (HUS). The patient was submitted to plasmapheresis and was treated with prednisolone 1 mg/kg, po, id. She started haemodialysis on the 14th day of internment, because of progressive worsening of renal function. The haematological abnormalities and LDH levels normalised, but there was no recovery of renal function. On the 16th february 2001 she restarted the cancer treatment with cytarabine and hydroxyurea and no recurrence of the HUS occurred. She died on the 19th september 2002 because of the CML progression. DISCUSSION HUS is a rare entity most frequently caused by infections, tumours, drugs, auto-immune diseases and pregnancy. There are some cases of idiopathic cause2. 718 CARTAS According to the published literature, CML is not a malignancy that separately induces the HUS, unlike certain solid tumours3. In this case report, the haematological control of the CML prior to the manifestation of the HUS and the absence of recurrence over 19 months of survival, after its remission, are factors that turn the hypothesis of the CML to be the cause of HUS very unlikely. The induction by chemotherapeutic agents is not described with hydroxyurea or cytarabine3. IFNhas been identified as cause of TM in CML patients4, 5. In the presented case, the absence of HUS recurrence after reintroduction of cytarabine and hydroxyurea, strains the hypothesis of induction by IFN- . Also in favour of these hypothesis is the known fact that the IFN- toxicity is grater with higher doses and longer periods of administration, conditions verified in this case1. BIBLIOGRAPHY 1. Fischer T, Talpaz M. Biology of interferon. In: Carella AM, Daley GQ, Eaves CJ, Goldman JM, Hehlmann R (eds.): Chronic Myeloid Leukaemia, Biology and Treatment. London: Martin Dunitz Ltd&#59; 135-49, 2001. 2. Remuzzi G, Ruggenenti P: The haemolytic uremic syndrome. Kidney Int 48: 2, 1995. 3. Gordon I, Kwaan H: Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura/haemolytic uremic syndrome in the cancer patient. Seminars in Thrombosis and Hemostasis 25 (2): 217-22, 1999. 4. Badid C, McGregor B, Faivre JM y cols.: Renal thrombotic microangiopathy induced by interferon . Nephrol Dial Transplant 16: 846-8, 2001. 5. Ohashi N, Yonemura K, Sugiura T y cols.: Withdrawal of interferon-alpha results in prompt resolution thrombocytopenia and hemolysis but not renal failure in haemolytic uremic syndrome caused by interferon-alpha. Am J Kidney Dis 41(3): E10, 2003. 719 "
    "pdfFichero" => "P1-E249-S122-A3752.pdf"
    "tienePdf" => true
  ]
  "idiomaDefecto" => "en"
  "url" => "/02116995/0000002500000006/v0_201502091332/X0211699505019316/v0_201502091333/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35344"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Cartas"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02116995/0000002500000006/v0_201502091332/X0211699505019316/v0_201502091333/en/P1-E249-S122-A3752.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699505019316?idApp=UINPBA000064"
]
Compartir
Información de la revista

Estadísticas

Siga este enlace para acceder al texto completo del artículo

ALPHA-INTERFERON RENAL TOXICITY
C. Carmo, H. Sá, M.F. Xavier da Cunha, M. Campos
Leído
6933
Veces
se ha leído el artículo
2299
Total PDF
4634
Total HTML
Compartir estadísticas
 array:20 [
  "pii" => "X0211699505019316"
  "issn" => "02116995"
  "estado" => "S300"
  "fechaPublicacion" => "2005-12-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia. 2005;25:718-9"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 3414
    "formatos" => array:3 [
      "EPUB" => 285
      "HTML" => 2615
      "PDF" => 514
    ]
  ]
  "Traduccion" => array:1 [
    "en" => array:16 [
      "pii" => "X2013251405019313"
      "issn" => "20132514"
      "estado" => "S300"
      "fechaPublicacion" => "2005-12-01"
      "documento" => "article"
      "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
      "subdocumento" => "fla"
      "cita" => "Nefrologia (English Version). 2005;25:718-9"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 2087
        "formatos" => array:3 [
          "EPUB" => 146
          "HTML" => 1728
          "PDF" => 213
        ]
      ]
      "en" => array:5 [
        "idiomaDefecto" => true
        "titulo" => "Alpha-interferon renal toxicity"
        "tieneTextoCompleto" => 0
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "718"
            "paginaFinal" => "719"
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "C. Carmo, H. Sá, M.F. Xavier da Cunha, M. Campos"
            "autores" => array:1 [
              0 => array:1 [
                "nombre" => "C. Carmo, H. Sá, M.F. Xavier da Cunha, M. Campos"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "en" => array:8 [
          "pii" => "X0211699505019316"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699505019316?idApp=UINPBA000064"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251405019313?idApp=UINPBA000064"
      "url" => "/20132514/0000002500000006/v0_201502091553/X2013251405019313/v0_201502091553/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:16 [
    "pii" => "X0211699505019308"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2005-12-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2005;25:720"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 5143
      "formatos" => array:3 [
        "EPUB" => 284
        "HTML" => 3843
        "PDF" => 1016
      ]
    ]
    "es" => array:9 [
      "idiomaDefecto" => true
      "titulo" => "EL CATETER VENOSO CENTRAL CRÓNICO TUNELIZADO AUMENTA LA MORTALIDAD EN HEMODIALISIS"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "720"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Chronic tunneled central venous catheter increases mortality in hemodialysis"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "J. Fernández-Gallego, V. López, M.A. Martín, R. Toledo"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "J. Fernández-Gallego, V. López, M.A. Martín, R. Toledo"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:8 [
        "pii" => "X2013251405019305"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251405019305?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699505019308?idApp=UINPBA000064"
    "url" => "/02116995/0000002500000006/v0_201502091332/X0211699505019308/v0_201502091333/es/main.assets"
  ]
  "itemAnterior" => array:16 [
    "pii" => "X0211699505019324"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2005-12-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2005;25:712-7"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 6650
      "formatos" => array:3 [
        "EPUB" => 296
        "HTML" => 5415
        "PDF" => 939
      ]
    ]
    "es" => array:9 [
      "idiomaDefecto" => true
      "titulo" => "NEFROPATÍA IGA CON PROLIFERACIÓN EXTRACAPILAR Y ANCA POSITIVOS"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "712"
          "paginaFinal" => "717"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "IgA nephropathy with crescentic glomerulonephritis and ANCA positive"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "J. Ara, J. Bonet, R. Rodríguez, E. Mirapeix, I. Agraz, R. Romero"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "J. Ara, J. Bonet, R. Rodríguez, E. Mirapeix, I. Agraz, R. Romero"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:8 [
        "pii" => "X2013251405019321"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251405019321?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699505019324?idApp=UINPBA000064"
    "url" => "/02116995/0000002500000006/v0_201502091332/X0211699505019324/v0_201502091333/es/main.assets"
  ]
  "en" => array:8 [
    "idiomaDefecto" => true
    "titulo" => "ALPHA-INTERFERON RENAL TOXICITY"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "718"
        "paginaFinal" => "719"
      ]
    ]
    "autores" => array:1 [
      0 => array:2 [
        "autoresLista" => "C. Carmo, H. Sá, M.F. Xavier da Cunha, M. Campos"
        "autores" => array:1 [
          0 => array:1 [
            "nombre" => "C. Carmo, H. Sá, M.F. Xavier da Cunha, M. Campos"
          ]
        ]
      ]
    ]
    "textoCompleto" => "NEFROLOGÍA. Volumen 25. Número 6. 2005 CARTAS Alpha-interferon renal toxicity C. Carmo*, H. Sá*, M. F. Xavier da Cunha** y M. Campos* *Servicio de Nefrología. Hospitais da Universidade de Coimbra. **Servicio de Anatomía Patológica. Hospitais da Universidade de Coimbra. Sr. Director: In 1982, the demonstrations of growth inhibiting properties led to the first clinical trials with IFN- , as a biological agent used in cancer treatment. Since then, it have been applied in the treatment of several malignancies and several adverse effects were reported1. CASE A 39 years old caucasian female, on the 9th january 2001, was observed for obnubilation. She had high blood pressure, anaemia, thrombocytopenia, moderate renal failure and an increase of serum LDH levels. She suffered from chronic myeloid leukaemia (CML) treated with IFN- , hydroxyurea and cytarabine, during 48 months, with haematological response. She had no other relevant antecedents and did not take other drugs. The patient was admitted to complementary study, cancer treatment was discontinued and anti-hypertensive treatment was started. During the first inpatient week she complained of orthopnoea, oedema and oliguria. Analysis revealed a non-immune haemolytic anaemia (Hg-7,9 g/dl, haptoglobin < 0,058 g/l, negative Combs tests, peripheral blood film showed schistocytes and spherocytes, LDH > 1.000 U/L) and renal function deterioration (ureic nitrogen-53 mg/dl and creatinine-6,8 mg/dl). The microbiological study of blood, urine and stools were negative. HBV, HCV and HIV serologies were negative. Serum values of C3 and C4 complement fractions were normal. Searches for circulating immune complexes, cryoglobulin, auto-antibodies were negative. Urinalysis showed proteinuria of 1.2 Correspondencia: Dra. Carmen do Carmo Servicio de Nefrología Hospitais da Universidade de Coimbra Avda. Dr. Bissaya Barreto, 52 3000-075 Coimbra (Portugal) E-mail: pmgf@mail.telepac.pt Fig. 1.--There is marked intimal edema, proliferation as well as necrosis. The vascular lumen is occluded by thrombi. The glomerular tuft is shrinked and the capilary wall is thickened showing double-contour (MT, × 200). g in 24 hours. Pregnancy test was negative. Renal ultrasound was normal. The histological study of the renal biopsy specimen revealed thrombotic microangiopathy (TM) (fig. 1). The clinical evaluation and the complementary study enabled the diagnosis of hemolytic uremic syndrome (HUS). The patient was submitted to plasmapheresis and was treated with prednisolone 1 mg/kg, po, id. She started haemodialysis on the 14th day of internment, because of progressive worsening of renal function. The haematological abnormalities and LDH levels normalised, but there was no recovery of renal function. On the 16th february 2001 she restarted the cancer treatment with cytarabine and hydroxyurea and no recurrence of the HUS occurred. She died on the 19th september 2002 because of the CML progression. DISCUSSION HUS is a rare entity most frequently caused by infections, tumours, drugs, auto-immune diseases and pregnancy. There are some cases of idiopathic cause2. 718 CARTAS According to the published literature, CML is not a malignancy that separately induces the HUS, unlike certain solid tumours3. In this case report, the haematological control of the CML prior to the manifestation of the HUS and the absence of recurrence over 19 months of survival, after its remission, are factors that turn the hypothesis of the CML to be the cause of HUS very unlikely. The induction by chemotherapeutic agents is not described with hydroxyurea or cytarabine3. IFNhas been identified as cause of TM in CML patients4, 5. In the presented case, the absence of HUS recurrence after reintroduction of cytarabine and hydroxyurea, strains the hypothesis of induction by IFN- . Also in favour of these hypothesis is the known fact that the IFN- toxicity is grater with higher doses and longer periods of administration, conditions verified in this case1. BIBLIOGRAPHY 1. Fischer T, Talpaz M. Biology of interferon. In: Carella AM, Daley GQ, Eaves CJ, Goldman JM, Hehlmann R (eds.): Chronic Myeloid Leukaemia, Biology and Treatment. London: Martin Dunitz Ltd&#59; 135-49, 2001. 2. Remuzzi G, Ruggenenti P: The haemolytic uremic syndrome. Kidney Int 48: 2, 1995. 3. Gordon I, Kwaan H: Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura/haemolytic uremic syndrome in the cancer patient. Seminars in Thrombosis and Hemostasis 25 (2): 217-22, 1999. 4. Badid C, McGregor B, Faivre JM y cols.: Renal thrombotic microangiopathy induced by interferon . Nephrol Dial Transplant 16: 846-8, 2001. 5. Ohashi N, Yonemura K, Sugiura T y cols.: Withdrawal of interferon-alpha results in prompt resolution thrombocytopenia and hemolysis but not renal failure in haemolytic uremic syndrome caused by interferon-alpha. Am J Kidney Dis 41(3): E10, 2003. 719 "
    "pdfFichero" => "P1-E249-S122-A3752.pdf"
    "tienePdf" => true
  ]
  "idiomaDefecto" => "en"
  "url" => "/02116995/0000002500000006/v0_201502091332/X0211699505019316/v0_201502091333/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35344"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Cartas"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02116995/0000002500000006/v0_201502091332/X0211699505019316/v0_201502091333/en/P1-E249-S122-A3752.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699505019316?idApp=UINPBA000064"
]
Información del artículo
ISSN: 02116995
Idioma original: Inglés
Datos actualizados diariamente
año/Mes Html Pdf Total
2024 Noviembre 1 2 3
2024 Octubre 43 44 87
2024 Septiembre 37 30 67
2024 Agosto 61 56 117
2024 Julio 32 21 53
2024 Junio 33 31 64
2024 Mayo 50 37 87
2024 Abril 40 37 77
2024 Marzo 28 28 56
2024 Febrero 43 38 81
2024 Enero 41 25 66
2023 Diciembre 47 27 74
2023 Noviembre 81 27 108
2023 Octubre 51 32 83
2023 Septiembre 90 39 129
2023 Agosto 41 30 71
2023 Julio 33 34 67
2023 Junio 43 41 84
2023 Mayo 70 39 109
2023 Abril 37 24 61
2023 Marzo 44 24 68
2023 Febrero 31 56 87
2023 Enero 32 27 59
2022 Diciembre 43 32 75
2022 Noviembre 27 31 58
2022 Octubre 42 39 81
2022 Septiembre 34 33 67
2022 Agosto 33 48 81
2022 Julio 33 38 71
2022 Junio 29 27 56
2022 Mayo 29 42 71
2022 Abril 30 53 83
2022 Marzo 33 60 93
2022 Febrero 31 47 78
2022 Enero 33 28 61
2021 Diciembre 25 48 73
2021 Noviembre 31 32 63
2021 Octubre 31 34 65
2021 Septiembre 23 37 60
2021 Agosto 24 43 67
2021 Julio 26 39 65
2021 Junio 24 28 52
2021 Mayo 25 30 55
2021 Abril 56 76 132
2021 Marzo 26 26 52
2021 Febrero 39 13 52
2021 Enero 22 18 40
2020 Diciembre 18 12 30
2020 Noviembre 21 13 34
2020 Octubre 12 16 28
2020 Septiembre 18 8 26
2020 Agosto 33 11 44
2020 Julio 25 12 37
2020 Junio 26 17 43
2020 Mayo 34 13 47
2020 Abril 29 10 39
2020 Marzo 26 14 40
2020 Febrero 35 18 53
2020 Enero 38 21 59
2019 Diciembre 31 18 49
2019 Noviembre 35 14 49
2019 Octubre 20 10 30
2019 Septiembre 22 29 51
2019 Agosto 16 5 21
2019 Julio 18 18 36
2019 Junio 31 15 46
2019 Mayo 29 17 46
2019 Abril 71 19 90
2019 Marzo 24 21 45
2019 Febrero 20 15 35
2019 Enero 20 17 37
2018 Diciembre 50 30 80
2018 Noviembre 72 17 89
2018 Octubre 41 10 51
2018 Septiembre 36 11 47
2018 Agosto 45 23 68
2018 Julio 33 14 47
2018 Junio 39 16 55
2018 Mayo 38 13 51
2018 Abril 44 7 51
2018 Marzo 40 7 47
2018 Febrero 30 6 36
2018 Enero 31 5 36
2017 Diciembre 35 7 42
2017 Noviembre 31 10 41
2017 Octubre 36 7 43
2017 Septiembre 27 11 38
2017 Agosto 25 7 32
2017 Julio 28 8 36
2017 Junio 28 8 36
2017 Mayo 33 8 41
2017 Abril 28 5 33
2017 Marzo 29 5 34
2017 Febrero 13 3 16
2017 Enero 17 7 24
2016 Diciembre 32 8 40
2016 Noviembre 32 5 37
2016 Octubre 63 8 71
2016 Septiembre 80 3 83
2016 Agosto 94 6 100
2016 Julio 125 10 135
2016 Junio 85 0 85
2016 Mayo 134 0 134
2016 Abril 71 0 71
2016 Marzo 60 0 60
2016 Febrero 85 0 85
2016 Enero 93 0 93
2015 Diciembre 84 0 84
2015 Noviembre 60 0 60
2015 Octubre 53 0 53
2015 Septiembre 66 0 66
2015 Agosto 46 0 46
2015 Julio 57 0 57
2015 Junio 20 0 20
2015 Mayo 48 0 48
2015 Abril 7 0 7
Mostrar todo

Siga este enlace para acceder al texto completo del artículo

Idiomas
Nefrología
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?